Some Wet Macular Degeneration Patients May Someday Need Eye Injections Only Twice a Year After Kodiak Trial

Kodiak's Zenkuda matched Eylea in a Phase 3 wet AMD trial, and 54% of patients reached six-month dosing. What families can ask a retina doctor.